8VC, a venture firm led by Palantir founder Joe Lonsdale, is seeking nearly $1 billion for its sixth fund, according to a regulatory filing. One area of focus for the firm is health tech and life sciences, representing over a quarter of 8VC deals, including the now publicly traded biotechs Senti Bio and Vir.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,